학술논문

Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Document Type
article
Source
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Subject
Science
Language
English
ISSN
2041-1723
Abstract
Loss of surface CD19 expression by leukemic cells leads to resistance and relapse to CD19-targeted CAR-T therapies. Here the authors show that loss of SPPL3 in malignant B cells results in hyperglycosylation of CD19.